Bottom line
GTHRX vs PHSYX: the short answer
GTHRX (INVESCO Health Care Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds.
PHSYX is cheaper at 0.79% vs 1.32% — a difference of $53 a year per $10,000 invested.
Over five years, PHSYX returned +8.1% a year vs +3.5% for GTHRX (reporting dates differ).
Updated Nov 19, 2026
GTHRX vs PHSYX side by side
| GTHRX | PHSYX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Invesco | Franklin Templeton |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.32% | 0.79% |
| Annual cost per $10k | $132 | $79 |
| 10-yr cost on $10k (prospectus) | $1,590 | $978 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0.5% | 0% |
| 1-yr return | +15.2% | +1.5% |
| 5-yr return (annualized) | +3.5% | +8.1% |
| 10-yr return (annualized) | +6.1% | +7.8% |
| Best quarter | +19.6% | — |
| Worst quarter | −16.5% | — |
| Net assets (fund) | $1.2B | $1.5B |
| Number of holdings | 82 | 115 |
| Portfolio turnover | 59% | 67% |
| Returns as of | Dec 31, 2025 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of GTHRX's top 25 holdings also appear in PHSYX's top 25.
| Holding | GTHRX | PHSYX |
|---|---|---|
| Eli Lilly and Co. | 10.59% | 13.15% |
| Johnson & Johnson | 6.76% | 8.46% |
| UnitedHealth Group Inc. | 6.17% | 6.93% |
| Merck & Co., Inc. | 4.59% | 4.88% |
| AbbVie Inc. | 4.03% | 6.05% |
| Gilead Sciences, Inc. | 3.63% | 2.63% |
| CVS Health Corp. | 2.52% | 2.74% |
| Cardinal Health, Inc. | 2.10% | 2.12% |
| Vertex Pharmaceuticals Inc. | 2.01% | 1.97% |
| Edwards Lifesciences Corp. | 1.56% | 2.80% |
| Thermo Fisher Scientific Inc. | 1.55% | 4.50% |
Source: SEC Form N-PORT
GTHRX top 10
- Eli Lilly and Co. — 10.59%
- Johnson & Johnson — 6.76%
- UnitedHealth Group Inc. — 6.17%
- Invesco Private Prime Fund — 4.67%
- Merck & Co., Inc. — 4.59%
- AbbVie Inc. — 4.03%
- Gilead Sciences, Inc. — 3.63%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
PHSYX top 10
- Eli Lilly & Co. — 13.15%
- Johnson & Johnson — 8.46%
- UnitedHealth Group, Inc. — 6.93%
- AbbVie, Inc. — 6.05%
- Novartis AG — 5.13%
- Merck & Co., Inc. — 4.88%
- AstraZeneca plc — 4.67%
- Thermo Fisher Scientific, Inc. — 4.50%
- Intuitive Surgical, Inc. — 4.04%
- Sanofi SA — 3.23%
FAQ
What is the difference between GTHRX and PHSYX?
GTHRX (INVESCO Health Care Fund) and PHSYX (Putnam Global Health Care Fund) are both mutual funds. PHSYX is cheaper at 0.79% vs 1.32% — a difference of $53 a year per $10,000 invested.
Which is cheaper, GTHRX or PHSYX?
PHSYX has the lower expense ratio (0.79%).
Should I own both GTHRX and PHSYX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.